Seed Implant Retention Score Predicts the Risk of Prolonged Urinary Retention After Prostate Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1445-1449

  Lee, Hoon K ^a,c   Adams, Marc T ^a,c   Shi, Qiuhu ^b   Basillote, Jay ^c   LaMonica, Joanne ^c   Miranda, Luis ^c   Motta, Joseph ^c  

^a Radiation Oncology   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Complication; Prostate cancer; Retention; Seed implant

Indexed keywords

BRACHYTHERAPY; COMPLICATION; MULTI VARIATE ANALYSIS; NEOADJUVANT HORMONE THERAPY; PROSTATE BRACHYTHERAPY; PROSTATE CANCERS; PROSTATE VOLUME; UNIVARIATE ANALYSIS; URINARY RETENTION; VALIDATION STUDY;

DECISION MAKING; MULTIVARIANT ANALYSIS; ONCOLOGY; PALLADIUM; SEED;

RADIOTHERAPY;

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; GONADORELIN AGONIST; IODINE 125; PALLADIUM 103;

AGED; ANTIANDROGEN THERAPY; ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE DURATION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SCORING SYSTEM; SEED IMPLANT RETENTION SCORE; URINE RETENTION;

AGED; ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; NEOADJUVANT THERAPY; ORGAN SIZE; PALLADIUM; PROSTATE; PROSTATIC NEOPLASMS; RADIOISOTOPES; RISK ASSESSMENT; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 77949545226     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.008     Document Type: Article

References (21)

1. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22 (1995) 209-234
2. Gutman S., Merrick G.S., Butler W.M., et al. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy. BJU Int 97 (2006) 62-68
3. Landis D., Wallner K., Locke J., et al. Late urinary function after prostate brachytherapy. Brachytherapy 1 (2002) 21-26
4. Kang S.K., Chou R.H., Dodge R.K., et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys 50 (2001) 937-945
5. Mabjeesh N.J., Chen J., Stenger A., et al. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy. Urology 70 (2007) 548-553
6. Keyes M., Schellenberg D., Moravan V., et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve?. Int J Radiat Oncol Biol Phys 64 (2006) 825-834
7. Schwartz D.J., Schild S.E., Wong W.W., et al. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys 61 (2005) 60-63
8. Sarosdy M.F. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Cancer 101 (2004) 754-760
9. Speight J.L., Shinohara K., Pickett B., et al. Prostate volume change after radioactive seed implantation: Possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys 48 (2000) 1461-1467
10. Sacco D.E., Daller M., Grocela J.A., et al. Corticosteroid use after prostate brachytherapy reduces the risk of acute urinary retention. BJU Int 91 (2003) 345-349
11. Mierzwa M.L., Barrett W.L., Redmond K., et al. Randomized trial to assess the efficacy of intraoperative steroid use in decreasing acute urinary retention after transperineal radioactive iodine-125 implantation for prostate cancer. Cancer 113 (2008) 2605-2609
12. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 52 (2002) 453-460
13. Bucci J., Morris W.J., Keyes M., et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 91-98
14. Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 712-719
15. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382
16. Elshaikh M.A., Ulchaker J.C., Reddy C.A., et al. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: Final report of a double-blind placebo-controlled randomized study. Int J Radiat Oncol Biol Phys 62 (2005) 164-169
17. Merrick G.S., Butler W.M., Wallner K.E., et al. Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology 60 (2002) 650-655
18. Ohashi T., Yorozu A., Toya K., et al. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy. Jpn J Clin Oncol 36 (2006) 285-289
19. Landis D.M., Schultz D., Cormack R., et al. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology 65 (2005) 750-754
20. Lee N., Wuu C.S., Brody R., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1457-1460
21. Sherertz T., Wallner K., Wang H., et al. Long-term urinary function after transperineal brachytherapy for patients with large prostate glands. Int J Radiat Oncol Biol Phys 51 (2001) 1241-1245